HK1002730A1 - Process for selectively producing hydrate crystals - Google Patents

Process for selectively producing hydrate crystals Download PDF

Info

Publication number
HK1002730A1
HK1002730A1 HK98101536A HK98101536A HK1002730A1 HK 1002730 A1 HK1002730 A1 HK 1002730A1 HK 98101536 A HK98101536 A HK 98101536A HK 98101536 A HK98101536 A HK 98101536A HK 1002730 A1 HK1002730 A1 HK 1002730A1
Authority
HK
Hong Kong
Prior art keywords
methyl
monohydrate
solvent
hemihydrate
carboxylic acid
Prior art date
Application number
HK98101536A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1002730B (en
Inventor
Sato Yukio
Sato Atsushi
Sumikawa Tatsuro
Uemura Tazuo
Original Assignee
Daiichi Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited
Publication of HK1002730B publication Critical patent/HK1002730B/en
Publication of HK1002730A1 publication Critical patent/HK1002730A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK98101536A 1990-03-01 1998-02-27 Process for selectively producing hydrate crystals HK1002730A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5045490 1990-03-01
JP50454/90 1990-03-01

Publications (2)

Publication Number Publication Date
HK1002730B HK1002730B (en) 1998-09-11
HK1002730A1 true HK1002730A1 (en) 1998-09-11

Family

ID=12859314

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101536A HK1002730A1 (en) 1990-03-01 1998-02-27 Process for selectively producing hydrate crystals

Country Status (13)

Country Link
US (1) US5545737A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0444678B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR970000045B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE157666T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69127485T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2106739T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3025276T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK1002730A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE910692A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN172207B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT96917B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW208013B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU48328B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
ES2272781T5 (es) * 2001-10-03 2010-04-06 Teva Pharmaceutical Industries Ltd. Preparacion de levofloxacino hemihidratado.
US7425628B2 (en) * 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
HUP0500285A3 (en) * 2001-11-29 2009-03-30 Teva Pharma Methods for the purification of levofloxacin
WO2004055025A1 (en) * 2002-12-16 2004-07-01 Ranbaxy Laboratories Limited Pure levofloxacin hemihydrate and processes for preparation thereof
KR100704641B1 (ko) * 2004-07-21 2007-04-06 주식회사유한양행 고순도의 레보플록사신 제조방법
EP1797101A4 (en) * 2004-09-17 2009-11-11 Matrix Lab Ltd IMPROVED PROCESS FOR THE PREPARATION OF LEVOFLOXACIN HEMIHYDRATE
US20070244318A1 (en) * 2004-11-08 2007-10-18 Rao Davuluri R Process for the Preparation of Levofloxacin Hemihydrate
ES2255871B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la obtencion de levofloxacino exento de sales.
CN1321121C (zh) * 2005-04-21 2007-06-13 浙江医药股份有限公司新昌制药厂 左氧氟沙星制备及后处理方法
US7964723B2 (en) * 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN101863904A (zh) * 2010-07-08 2010-10-20 浙江东亚药业有限公司 一种高纯度左氧氟沙星半水合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE203719C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1907-11-02 1908-10-20
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS57131769A (en) * 1981-02-10 1982-08-14 Kissei Pharmaceut Co Ltd 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate, its preparation and drug containing the same
JPS5843977A (ja) * 1981-09-09 1983-03-14 Dai Ichi Seiyaku Co Ltd ピリドベンズオキサジン誘導体の製法
JPS60226855A (ja) * 1984-04-26 1985-11-12 Nippon Kayaku Co Ltd N−ベンジルオキシカルボニル−l−スレオニンアミド・1/2水和物およびその製造法
ZA864518B (en) * 1985-06-20 1987-03-25 Daiichi Seiyaku Co Optically active pyridobenzoxazine derivatives and intermediates thereof
NO166131C (no) * 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
MY104139A (en) * 1988-08-09 1994-02-28 Daiichi Seiyaku Co Antimicrobial agent for animals
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate

Also Published As

Publication number Publication date
TW208013B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-21
DE69127485D1 (de) 1997-10-09
YU35491A (sh) 1994-04-05
IE910692A1 (en) 1991-09-11
PT96917B (pt) 1998-07-31
DE69127485T2 (de) 1998-04-02
GR3025276T3 (en) 1998-02-27
YU48328B (sh) 1998-05-15
ES2106739T3 (es) 1997-11-16
KR910016748A (ko) 1991-11-05
PT96917A (pt) 1991-10-31
EP0444678A1 (en) 1991-09-04
US5545737A (en) 1996-08-13
EP0444678B1 (en) 1997-09-03
IN172207B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-01
KR970000045B1 (ko) 1997-01-04
ATE157666T1 (de) 1997-09-15

Similar Documents

Publication Publication Date Title
EP0444678B1 (en) Process for selectively producing hydrate crystals
HK1002730B (en) Process for selectively producing hydrate crystals
HK1043725A1 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US5677443A (en) Bioavailable crystalline form of cefuroxime axetil
CA2686519C (en) A process for the preparation of the stable, amorphous calcium salt of (6s)-n(5)-methyl-5, 6, 7, 8-tetrahydrofolic acid
CA2396426A1 (en) Preparation method of azithromycin dihydrate
JP2740362B2 (ja) 安定な固体状2‐オクチニルアデノシンおよびその製造法
JP2005509037A (ja) 結晶イミペネム製造方法
US5847118A (en) Methods for the manufacture of amorphous cefuroxime axetil
MXPA98007851A (es) Metodo para obtener enantiomeros puros de un derivado de piridazinona.
WO2004055025A1 (en) Pure levofloxacin hemihydrate and processes for preparation thereof
JP3135672B2 (ja) マクロライド抗生物質の結晶及び溶媒和物
RU2152947C2 (ru) Способ приготовления аморфного цефуроксима аксетила, имеющего низкую точку плавления
KR100375957B1 (ko) D4t 동질이상 i 형의 제조방법
JP3793583B2 (ja) 抗菌性化合物の結晶
JP3896226B2 (ja) ロキシスロマイシンの精製方法
JPH03275668A (ja) 光学活性トリプトファンの晶析法
US4962222A (en) Preparation process of α-l-aspartyl-l-phenylalanine methyl ester having low hygroscopicity
JP3105572B2 (ja) 水和物の選択的製法
JP4655930B2 (ja) キノリンカルボン酸誘導体溶媒和物の結晶
CA2120874E (en) Form of form 1 ranitidine
JP4200593B2 (ja) 結晶質l−アスコルビン酸−2−リン酸エステルナトリウム塩およびその製造方法
JPH0840984A (ja) テトラキス〔3−(3’,5’−ジ第三ブチル−4’−ヒドロキシフェニル)プロピオニルオキシメチル〕メタンの顆粒化方法
JP3800356B2 (ja) エトポシドの異性体の生成を抑える方法
US5670671A (en) Process for the production of an improved form of form 1 ranitidine

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110227